K
Kazuo Tsubota
Researcher at Keio University
Publications - 1421
Citations - 57308
Kazuo Tsubota is an academic researcher from Keio University. The author has contributed to research in topics: Cornea & Visual acuity. The author has an hindex of 105, co-authored 1379 publications receiving 48991 citations. Previous affiliations of Kazuo Tsubota include Chiba University & Showa University.
Papers
More filters
Journal ArticleDOI
Blinking is controlled primarily by ocular surface conditions.
TL;DR: The blink rate and the newly introduced measurement, the maximum blink interval, should prove useful in assessing factors that cause dry eye and should contribute to the understanding and treatment of dry eyes.
Journal ArticleDOI
Treatment of dry eye by autologous serum application in sjögrenʼs syndrome
TL;DR: Autologous serum application is a safe and efficient way to provide essential components to the ocular surface in the treatment of dry eye associated with Sjögren's syndrome.
Journal ArticleDOI
Autologous serum application in the treatment of neurotrophic keratopathy
Yukihiro Matsumoto,Yukihiro Matsumoto,Murat Dogru,Eiki Goto,Eiki Goto,Yoshiki Ohashi,Takashi Kojima,Reiko Ishida,Kazuo Tsubota,Kazuo Tsubota +9 more
TL;DR: In this paper, the effect of topical autologous serum application for epithelial disorders in neurotrophic keratopathy (NK) was evaluated using a case series of 14 eyes of 11 patients seen at Tokyo Dental College, Ichikawa General Hospital, Department of Ophthalmology.
Journal ArticleDOI
Dry eye after laser in situ keratomileusis
TL;DR: Subjective score for dryness was increased after laser in situ keratomileusis and use of artificial tears in the early postoperative period may help to prevent unwanted symptoms and ocular surface damage.
Journal ArticleDOI
Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders
Kazuo Tsubota,Kazuo Tsubota,Ikuko Toda,Ikuko Toda,H Saito,H Saito,Naoshi Shinozaki,Naoshi Shinozaki,Jun Shimazaki,Jun Shimazaki +9 more
TL;DR: Limbal allograft transplantation with intensive immunosuppression by cyclosporine and high-dose steroids appears to be a promising surgical intervention for the reconstruction of corneas affected by severe ocular surface disease.